Impact on quality of life (QoL) of FEC-T compared with FEC or E-CMF: UK Taxotere as Adjuvant Chemotherapy Trial (TACT) 2-year follow-upPenelope Hopwood, David Cameron, L. Johnson et al.|Journal of Clinical Oncology|2008Cited by 3